Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Omeros Corp (OMER)  
$3.13 0.02 (0.63%) as of 4:30 Mon 4/29


Download
   
Exchange: Nasdaq Small Cap
Security Type: Common
Shares Out: 61,650,000
Market Cap: 192.96(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.08 - $7.57
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    : 6.1
Insider 3/6 Months : 6.7
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Omeros is a commercial-stage biopharmaceutical company. Co. is focused on discovering, developing and commercializing small-molecule and protein therapeutics for larger-market as well as orphan indications targeting immunologic diseases. Co.'s drug candidate narsoplimab is the subject of a biologics license application pending before the U.S. Food and Drug Administration for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy. Co. has various late-stage clinical development programs in its pipeline, which are focused on: complement-mediated disorders, including immunoglobulin A nephropathy, atypical hemolytic uremic syndrome and COVID-19.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 25,000 25,000 25,000
Total Buy Value $0 $40,500 $40,500 $40,500
Total People Bought 0 2 2 2
Total Buy Transactions 0 2 2 2
Total Shares Sold 0 0 10,000 10,000
Total Sell Value $0 $0 $64,950 $64,950
Total People Sold 0 0 2 2
Total Sell Transactions 0 0 2 2
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 163
  Page 6 of 7  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Cable Thomas J. Director   –       •      –    2014-03-03 4 AS $12.76 $63,810 D/D (5,000) 67,067     -
   Demopulos Gregory A Md Chairman, CEO & President   •       •       •   2013-12-31 4 OE $0.98 $9,800 D/D 10,000 1,506,822     -
   Cable Thomas J. Director   –       •      –    2013-12-11 4 AS $7.08 $35,400 D/D (5,000) 72,067     -
   Aspiri Ray Director   –       •      –    2013-10-24 4 OE $4.53 $178,800 D/D 25,000 40,306     -
   Cable Thomas J. Director   –       •      –    2013-07-03 4 AS $5.21 $26,050 D/D (5,000) 77,067     -
   Kelbon Marcia S. VP Patent and General Counsel   •       –      –    2013-04-11 4 OE $0.98 $5,001 D/D 5,103 122,250     -
   Cable Thomas J. Director   –       •      –    2013-04-10 4 AS $3.98 $19,900 D/D (5,000) 82,067     -
   Cable Thomas J. Director   –       •      –    2013-01-08 4 AS $6.19 $30,950 D/D (5,000) 87,067     -
   Kelbon Marcia S. VP Patent and General Counsel   •       –      –    2013-01-04 4 OE $0.98 $9,800 D/D 10,000 117,147     -
   Aspiri Ray Director   –       •      –    2013-01-04 4 B $5.72 $228,800 I/I 40,000 186,872 2.1     -
   Demopulos Peter A Md Director   –       •      –    2013-01-03 4 B $5.42 $50,650 D/D 9,345 175,067 2.39     -
   Hanish Arnold C Director   –       •      –    2013-01-03 4 B $5.58 $11,160 D/D 2,000 2,400 2.39     -
   Demopulos Gregory A Md Chairman, CEO & President   •       •       •   2012-12-31 4 OE $0.98 $9,800 D/D 10,000 1,394,301     -
   Hanish Arnold C Director   –       •      –    2012-09-26 3 IO $0.00 $0 D/D 0 400     -
   Cable Thomas J. Director   –       •      –    2012-09-26 4 AS $9.60 $48,000 D/D (5,000) 92,067     -
   Cable Thomas J. Director   –       •      –    2012-09-07 4 GD $0.00 $0 D/D 2,000 97,067     -
   Demopulos Peter A Md Director   –       •      –    2012-06-27 4 B $10.25 $150,009 D/D 14,635 165,722 2.39     -
   Demopulos Peter A Md Director   –       •      –    2012-03-12 4 OE $5.92 $79,995 D/D 11,666 151,087     -
   Demopulos Gregory A Md Chairman, CEO & President   •       •       •   2011-08-22 4 OE $0.98 $9,800 D/D 10,000 1,236,822     -
   Demopulos Gregory A Md Chairman, CEO & President   •       •       •   2011-08-18 4 OE $0.52 $802 D/D 1,542 1,226,822     -
   Demopulos Peter A Md Director   –       •      –    2011-05-16 4 B $4.95 $103,963 D/D 21,000 139,421 2.39     -
   Demopulos Peter A Md Director   –       •      –    2011-05-13 4 B $5.00 $94,918 D/D 19,000 118,421 2.39     -
   Cable Thomas J. Director   –       •      –    2010-10-01 4 OE $0.98 $15,000 D/D 15,306 99,067     -
   Cable Thomas J. Director   –       •      –    2010-09-22 4 OE $0.52 $3,980 D/D 7,653 83,761     -
   Hood Leroy E. Md Phd Director   –       •      –    2010-07-01 4 OE $0.52 $20,306 D/D 25,510 54,390     -
  163 Records found
  1  2  3  4  5  6  7   
  Page 6 of 7
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us